Mostrar el registro sencillo del ítem
dc.contributor.author | Lazarus, Jeffrey V | |
dc.contributor.author | Ortiz, Alberto | |
dc.contributor.author | Tyrovolas, Stefanos | |
dc.contributor.author | Fernández, Esteve | |
dc.contributor.author | Guy, Danielle | |
dc.contributor.author | White, Trenton M | |
dc.contributor.author | Ma, Rui | |
dc.contributor.author | Hay, Simon I | |
dc.contributor.author | Naghavi, Mohsen | |
dc.contributor.author | Soriano, Joan B | |
dc.contributor.author | The GBD 2019 Spain Collaborators | |
dc.contributor.author | Padron-Monedero, Alicia | |
dc.date.accessioned | 2023-04-24T11:03:27Z | |
dc.date.available | 2023-04-24T11:03:27Z | |
dc.date.issued | 2022-12-07 | |
dc.identifier.citation | Sci Rep. 2022 Dec 7;12(1):21154. | es_ES |
dc.identifier.uri | http://hdl.handle.net/20.500.12105/15876 | |
dc.description.abstract | This study aimed to report mortality, risk factors, and burden of diseases in Spain. The Global Burden of Disease, Injuries, and Risk Factors 2019 estimates the burden due to 369 diseases, injuries, and impairments and 87 risk factors and risk factor combinations. Here, we detail the updated Spain 1990-2019 burden of disease estimates and project certain metrics up to 2030. In 2019, leading causes of death were ischaemic heart disease, stroke, chronic obstructive pulmonary disease, Alzheimer's disease, and lung cancer. Main causes of disability adjusted life years (DALYs) were ischaemic heart disease, diabetes, lung cancer, low back pain, and stroke. Leading DALYs risk factors included smoking, high body mass index, and high fasting plasma glucose. Spain scored 74/100 among all health-related Sustainable Development Goals (SDGs) indicators, ranking 20 of 195 countries and territories. We forecasted that by 2030, Spain would outpace Japan, the United States, and the European Union. Behavioural risk factors, such as smoking and poor diet, and environmental factors added a significant burden to the Spanish population's health in 2019. Monitoring these trends, particularly in light of COVID-19, is essential to prioritise interventions that will reduce the future burden of disease to meet population health and SDG commitments. | es_ES |
dc.description.sponsorship | The GBD Study is funded by the Bill and Melinda Gates foundation. J.V.L., D.G., and T.M.W. acknowledge support to ISGlobal from the Spanish Ministry of Science, Innovation and Universities through the "Centro de Excelencia Severo Ochoa 2019-2023" Programme (CEX2018-000806-S), and from the Government of Catalonia, Spain, through the CERCA Programme. J.L.A-M. was funded by the Instituto de Salud Carlos III (Grant Number PI19/00150). I.G-V. was supported by the Instituto de Salud Carlos III, Ministerio de Ciencia e Innovación. A.O. was funded by the Instituto de Salud Carlos III (ISCIII) RICORS program to RICORS2040 (RD21/0005/0001), European Union—NextGenerationEU, Mecanismo para la Recuperación y la Resiliencia (MRR) and SPACKDc PMP21/00109, and FEDER. E.F. is partly supported by the Ministry of Universities and Research, Government of Catalonia (2017SGR319) and receives institutional support from IDIBELL. R.T-S. is supported by the Spanish Ministry of Science and Innovation, Institute of Health Carlos III, and INCLIVA (PID2021-129099OB-I00). | es_ES |
dc.language.iso | eng | es_ES |
dc.publisher | Nature Publishing Group | es_ES |
dc.type.hasVersion | VoR | es_ES |
dc.rights.uri | http://creativecommons.org/licenses/by/4.0/ | * |
dc.subject.mesh | COVID-19 | es_ES |
dc.subject.mesh | Myocardial Ischemia | es_ES |
dc.subject.mesh | Lung Neoplasms | es_ES |
dc.subject.mesh | Humans | es_ES |
dc.subject.mesh | Sustainable Development | es_ES |
dc.subject.mesh | Spain | es_ES |
dc.title | A GBD 2019 study of health and Sustainable Development Goal gains and forecasts to 2030 in Spain | es_ES |
dc.type | journal article | es_ES |
dc.rights.license | Atribución 4.0 Internacional | * |
dc.identifier.pubmedID | 36477107 | es_ES |
dc.format.volume | 12 | es_ES |
dc.format.number | 1 | es_ES |
dc.format.page | 21154 | es_ES |
dc.identifier.doi | 10.1038/s41598-022-24719-z | es_ES |
dc.contributor.funder | Bill & Melinda Gates Foundation | es_ES |
dc.contributor.funder | Ministerio de Ciencia e Innovación. Centro de Excelencia Severo Ochoa (España) | es_ES |
dc.contributor.funder | Government of Catalonia (España) | es_ES |
dc.contributor.funder | Instituto de Salud Carlos III | es_ES |
dc.contributor.funder | Unión Europea. Fondo Europeo de Desarrollo Regional (FEDER/ERDF) | es_ES |
dc.contributor.funder | Ministerio de Universidades (España) | es_ES |
dc.contributor.funder | Instituto de Investigación Biomédica de Bellvitge (España) | es_ES |
dc.contributor.funder | Instituto de Investigación Sanitaria Fundación para la Investigación del Hospital Clínico de Valencia (España) | es_ES |
dc.description.peerreviewed | Sí | es_ES |
dc.identifier.e-issn | 2045-2322 | es_ES |
dc.relation.publisherversion | https://doi.org/10.1038/s41598-022-24719-z | es_ES |
dc.identifier.journal | Scientific reports | es_ES |
dc.repisalud.centro | ISCIII::Escuela Nacional de Sanidad | es_ES |
dc.repisalud.institucion | ISCIII | es_ES |
dc.rights.accessRights | open access | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/ISCIII/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020 (ISCIII)/PMP21%2F00109/ES/SPAIN CKD CAUSE (SPACKDC)/ | es_ES |
dc.relation.projectFECYT | info:eu-repo/grantAgreement/ES/CEX2018-000806-S | es_ES |
dc.relation.projectFIS | info:fis/Instituto de Salud Carlos III/Programa Estatal de Generación de Conocimiento y Fortalecimiento del Sistema Español de I+D+I/Subprograma Estatal de Generación de Conocimiento/PI19 - Proyectos de investigacion en salud (AES 2019). Modalidad proyectos en salud. (2019)/PI19/00150 | es_ES |
dc.relation.projectFIS | info:eu-repo/grantAgreement/ES/RD21/0005/0001 | es_ES |